首页 | 本学科首页   官方微博 | 高级检索  
     

信必可干预支气管哮喘慢性持续期治疗的临床分析
引用本文:郑振经. 信必可干预支气管哮喘慢性持续期治疗的临床分析[J]. 中国医药指南, 2012, 0(17): 53-54
作者姓名:郑振经
作者单位:广东省徐闻县中医院,广东湛江524100
摘    要:目的观察信必可治疗支气管哮喘慢性持续期患者的临床疗效。方法将70例支气管哮喘患者随机分为观察组和对照组。观察组给予吸入信必可治疗,对照组给予糖皮质激素吸入剂常规治疗,治疗8周后观察两组患者临床症状以及肺功能变化的情况。结果经治疗后观察组的临床疗效及肺功能改善情况均优于对照组。结论信必可治疗支气管哮喘慢性持续期患者临床疗效可靠,值得在临床上广泛推广。

关 键 词:哮喘  慢性持续期  信必可

The Clinical Analysis of Xinbike Intervention Bronchial Asthma Clinical Analysis of Chronic Duration
ZHENG Zhen-jing. The Clinical Analysis of Xinbike Intervention Bronchial Asthma Clinical Analysis of Chronic Duration[J]. Guide of China Medicine, 2012, 0(17): 53-54
Authors:ZHENG Zhen-jing
Affiliation:ZHENG Zhen-jing(Traditional Chinese Medicine Hospital of Xuwen,Zhanjiaing 524100,China)
Abstract:Objective To observe the clinical curative effect of budesonide and formoterol fumarate powder for inhalation to the bronchus asthma patients with chronic duration.Methods 70 cases of bronchial asthma patients were divided into two groups.The observation group was given budesonide and formoterol fumarate powder for inhalation.The control group was given budesonide.To observe the clinical symptoms and the changes of lung function after 8 weeks treatment.Results The clinical curative effect of the observation group and improve lung function are better than the control group after therapy.Conclusion Budesonide and formoterol fumarate powder for inhalation can treat the bronchus asthma patients in chronic duration with clinical curative effect,and is worth in clinical widely.
Keywords:Asthma  Chronic duration  Budesonide and formoterol fumarate powder for inhalation
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号